Axial Spondyloarthritis (AXSPA) Treatment Market Will Drive Growth Owing To Increasing Disease Prevalence
The axial spondyloarthritis (axSpA) treatment market comprises medications for managing the signs and symptoms of axSpA. AxSpA causes chronic inflammation of the spine and pelvis. Common symptoms include lower back pain, stiffness in the back, arthritis, and fatigue. Biologics such as TNF inhibitors and IL-17 inhibitors are largely used in treating